arrow
G

Giedre Krenciute

St Jude Children's Research Hospital
H指数:27
被引数:4,151

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma

靶向B7-H3-CAR T细胞中的Regnase-1重编程肿瘤微环境并增强对骨肉瘤的抗肿瘤功效

2026-09-010
PRE
Author Correction: cBAF complex components and MYC cooperate early in CD8+ T cell fate

作者更正:cBAF 复合体组分和 MYC 在 CD8+ T 细胞命运决定早期协同作用

Nature
IF48.5
2026-06-240
PRE
Computationally structurally optimized IL13Rα2-B7-H3 tandem CAR T cells overcome antigen-heterogeneity mediated tumor escape in a brain tumor model

计算结构优化的IL13Rα2-B7-H3串联CAR-T细胞克服了抗原异质性介导的肿瘤逃逸,在脑肿瘤模型中。

2025-11-010
OAAI
Increased capacity for expansion, not persistence, improves preclinical B7-H3 targeted CAR T cell therapy against aggressive Group 3 medulloblastomas

扩增能力而非持久性增强,可改善针对侵袭性Group 3髓母细胞瘤的B7-H3靶向CAR T细胞疗法的前临床效果

2025-11-010
OAAI
CELL-FREE DNA ANALYSIS OF CSF SAMPLES ENABLES ASSESSMENT OF TREATMENT RESPONSE AND TRACKING OF CAR T-CELLS POST-LOCOREGIONAL DELIVERY IN PEDIATRIC BRAIN TUMOR PATIENTS

脑脊液样本的无细胞DNA分析能够评估治疗反应,并追踪在儿科脑肿瘤患者中局部区域给药后的CAR T细胞。

2025-11-010
OAAI
Locoregional B7-H3 CAR-T cells for relapsed/refractory CNS tumors: preliminary clinical experience of the Loc3CAR trial

局部区域B7-H3 CAR-T细胞治疗复发/难治性中枢神经系统肿瘤:Loc3CAR试验的初步临床经验

2025-11-010
OAAI
Tumor inflammation-associated neurotoxicities for patients treated with intracranial B7-H3-CAR T cells on a phase I clinical trial

I期临床试验中接受颅内B7-H3-CAR T细胞治疗的患者的肿瘤炎症相关神经毒性

2025-11-010
OAAI
Early methionine availability attenuates T cell exhaustion

早期蛋氨酸利用减弱t 细胞耗竭

2025-07-230
OA